It’s less than a year since cannabis was legalised for medical purposes, and investors haven’t let the grass grow beneath their feet. Australia already ranks among the countries with the highest number of recreational users.
It’s less than a year since cannabis was legalised for medical purposes, and investors haven’t let the grass grow beneath their feet. Australia already ranks among the countries with the highest number of recreational users. The history of cannabis cultivation here dates back to the First Fleet, when settlers brought along seeds to make hemp. Now the aptly named weed is at the centre of a growth industry aimed at treating many common ailments.
Let’s get one point straight. The marijuana that is smoked is not the same stuff that could soon ease itching from eczema, let insomniacs sleep or improve cancer treatments. The plants look similar but they have vastly different chemical make-up. Cannabis contains 113 types of a compound called cannabinoid. Just one of those, THC, brings a state of euphoria. Plants can be bred to have thousands of different concentrations and combinations of each compound, giving them the potential to treat many different ills. No one compound works alone. They all do, creating what is called an entourage effect. Now that it’s legal, the challenge is to test exactly which plants have which effects.
Harry Karelis is doing just that. Before the year is out, a company he chairs, Zelda Therapeutics, will start its first clinical trial in partnership with the University of Western Australia on formulations to treat insomnia. The university is a leader in sleep disorders, with its own sleep labs. “Picture a controlled environment where you have a relaxing night’s sleep with 24 leads attached to your brain, your lungs, your heart, your limbs and a camera monitoring your night’s sleep,” says Karelis. “We will be monitoring pretty much everything that is going on, including blood. This will be a randomised, crossover, placebo-controlled trial. That means the gold standard. If we show that our medicine works under those conditions, then it works.”
This story is from the October 2017 edition of Money Magazine Australia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the October 2017 edition of Money Magazine Australia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
Is the public market shrinking?
Australia needs a healthy stock market to give companies access to funds and to allow retail investors to build wealth.
India: three steps to transformation
Massive investment and extensive reforms turbocharge the economy.
The ballet of business
Changing direction, products, models and marketing is a hard task for a business. We chart what it takes to turn a business around, plus profile four successful pivots.
Save money and the planet
Could the high cost of living give us the incentive we need to reduce how much water and energy we use or waste? These eco-friendly household tips will help you do just that.
AI adoption is the new black
Artificial intelligence is set to reshape the commercial world, and small enterprises can’t afford to miss the boat.
Spam attack! Murky laws jam our inboxes
Unwanted marketing material is one of the pain points of modern life.
From rags to riches in style
Rich Tran sported a bowl cut until he was 14 years old and had no intention of becoming a hairdresser.
New work deals are killing the 'old' office
The Covid pandemic and the subsequent lockdowns accelerated the trend to more people working from home. It was a mixed experience.
Points taken: the truth about rewards
Can hopping between credit cards really boost your frequent flyer haul and give you cheap or free travel - or is it doing more harm than good behind the scenes? Money puts it to the test.
Shortcuts to own a home
Innovative ideas with a focus on low costs and sustainability could help solve the housing crunch.